# ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy

> **NCT02332109** · — · COMPLETED · sponsor: **TRB Chemedica AG** · enrollment: 29 (actual)

## Conditions studied

- Fuchs' Endothelial Dystrophy
- Corneal Edema

## Interventions

- **DEVICE:** ODM 5

## Key facts

- **NCT ID:** NCT02332109
- **Lead sponsor:** TRB Chemedica AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332109, "ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02332109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*